- Home
- IRMD vs BBNX Comparison
IRMD vs BBNX Comparison
Compare IRMD & BBNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IRMD | BBNX |
|---|---|---|
| Founded | 1992 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 997.9M |
| IPO Year | 2014 | 2025 |
Fundamental Metrics
Financial Performance| Metric | IRMD | BBNX |
|---|---|---|
| Price | $85.55 | $18.33 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 3 | 15 |
| Target Price | ★ $118.00 | $25.10 |
| AVG Volume (30 Days) | 84.7K | ★ 1.0M |
| Earning Date | 10-30-2026 | 10-27-2026 |
| Dividend Yield | ★ 0.95% | N/A |
| EPS Growth | 16.67 | ★ 78.95 |
| EPS | ★ 0.86 | N/A |
| Revenue | $83,814,000.00 | ★ $100,251,000.00 |
| Revenue This Year | $9.85 | $25.37 |
| Revenue Next Year | $13.07 | $47.08 |
| P/E Ratio | $97.44 | ★ N/A |
| Revenue Growth | 14.43 | ★ 53.94 |
| 52 Week Low | $76.45 | $8.80 |
| 52 Week High | $107.90 | $32.71 |
Technical Indicators
Market Signals| Indicator | IRMD | BBNX |
|---|---|---|
| Relative Strength Index (RSI) | 48.13 | 48.09 |
| Support Level | $85.00 | $15.92 |
| Resistance Level | $88.59 | $20.48 |
| Average True Range (ATR) | 1.88 | 1.27 |
| MACD | -0.41 | 0.16 |
| Stochastic Oscillator | 32.76 | 33.58 |
Price Performance
Historical ComparisonAbout IRMD iRadimed Corporation
iRadimed Corp develops, manufactures, markets, and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system, which is designed to be safe for use during MRI procedures. The MRI products of the company are sold to hospitals and acute care facilities in the United States and internationally. It generates the majority revenue from United States.
About BBNX Beta Bionics Inc.
Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company's product includes the iLet Bionic Pancreas (iLet). The company operates as a single segment, focused on the development, manufacture, and sale of the iLet.